Wissenschaftliche Publikationen

12. September 2024 / Haematologica

A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma

J. Krüger
M. Obenaus
I.W. Blau
D. Hoser
M. Vaegler
H. Rauschenbach
I. Anagnostopoulos
K. Jöhrens
V. Scheuplein
E. Kieback
J. Böhme
A.C. Von Brünneck
J. Krönke
A. Busse
G. Willimsky
T. Blankenstein
A. Pezzutto
U. Keller
A. Nogai

N-myristoyltransferase inhibition is synthetic lethal in MYC-deregulated cancers

G.A. Lueg
M. Faronato
A. Gorelik
A.G. Grocin
E. Caamano-Gutierrez
F. Falciani
R. Solari
R. Carr
A.S. Bell
E. Bartlett
J.A. Hutton
M. Llorian-Sopena
P. Chakravarty
B. Brzezicha
M. Janz
M.J. Garnett
D.P. Calado
E.W. Tate

Co-activation of NF-κB and MYC renders cancer cells addicted to IL6 for survival and phenotypic stability

R.R. Barbosa
A.Q. Xu
D. D'Andrea
F. Copley
H. Patel
P. Chakravarty
A. Clear
M. Calaminici
M. Janz
B. Zhang
M. Schmidt-Supprian
J. Wang
J.G. Gribben
R. Tooze
J. Fitzgibbon
G. Franzoso
K. Rajewsky
D.P. Calado

Downregulation of genes involved in DNA repair and differential expression of transcription regulators and phosphatases precede IgM-induced apoptosis in the Burkitt's lymphoma cell line BL60-2

B. Schories
M. Janz
B. Doerken
K. Bommert

Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells

S. Lentzsch
M. Gries
M. Janz
R. Bargou
B. Doerken
M.Y. Mapara

Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial

R.F. Schlenk
A. Benner
F. Hartmann
F. del Valle
C. Weber
H. Pralle
J.T. Fischer
U. Gunzer
A. Pezzutto
W. Weber
W. Grimminger
J. Preiss
M. Hensel
S. Froehling
K. Doehner
R. Haas
H. Doehner

c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis

S. Mathas
A. Lietz
I. Anagnostopoulos
F. Hummel
B. Wiesner
M. Janz
F. Jundt
B. Hirsch
K. Joehrens-Leder
H.P. Vornlocher
K. Bommert
H. Stein
B. Doerken

Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization

J. Westermann
T. Nguyen-Hoai
A. Mollweide
G. Richter
O. Schmetzer
H.J. Kim
T. Blankenstein
B. Doerken
A. Pezzutto

Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties

J. Westermann
I.J. Koerner
J. Kopp
S. Kurz
M. Zenke
B. Doerken
A. Pezzutto

Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia

J. Westermann
J. Kopp
I. Koerner
G. Richter
Z. Qin
T. Blankenstein
B. Doerken
A. Pezzutto